Literature DB >> 10037723

The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer.

S Guerrette1, S Acharya, R Fishel.   

Abstract

Germline mutations in two human mismatch repair (MMR) genes, hMSH2 and hMLH1, appear to account for approximately 70% of the common cancer susceptibility syndrome hereditary nonpolyposis colorectal cancer (HNPCC). Although the hMLH1 protein has been found to copurify with another MMR protein hPMS2 as a heterodimer, their function in MMR is unknown. In this study, we have identified the physical interaction regions of both hMLH1 with hPMS2. We then examined the effects of hMLH1 missense alterations found in HNPCC kindreds for their interaction with hPMS2. Four of these missense alterations (L574P, K616Delta, R659P, and A681T) displayed >95% reduction in binding to hPMS2. Two additional missense alterations (K618A and K618T) displayed a >85% reduction in binding to hPMS2, whereas three missense alterations (S44F, V506A, and E578G) displayed 25-65% reduction in binding to hPMS2. Interestingly, two HNPCC missense alterations (Q542L and L582V) contained within the consensus interaction region displayed no effect on interaction with hPMS2, suggesting that they may affect other functions of hMLH1. These data confirm that functional deficiencies in the interaction of hMLH1 with hPMS2 are associated with HNPCC as well as suggest that other unknown functional alteration of the human MutL homologues may lead to tumorigenesis in HNPCC kindreds.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037723     DOI: 10.1074/jbc.274.10.6336

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.

Authors:  A Brieger; J Trojan; J Raedle; G Plotz; S Zeuzem
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

3.  Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.

Authors:  Xiaosheng Wu; Jeffrey L Platt; Marilia Cascalho
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  Human PMS2 gene family: origin, molecular evolution, and biological implications.

Authors:  D G Shpakovskii; E K Shematorova; G V Shpakovskii
Journal:  Dokl Biochem Biophys       Date:  2006 May-Jun       Impact factor: 0.788

5.  exo1-Dependent mutator mutations: model system for studying functional interactions in mismatch repair.

Authors:  N S Amin; M N Nguyen; S Oh; R D Kolodner
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  hMSH4-hMSH5 adenosine nucleotide processing and interactions with homologous recombination machinery.

Authors:  Timothy Snowden; Kang-Sup Shim; Christoph Schmutte; Samir Acharya; Richard Fishel
Journal:  J Biol Chem       Date:  2007-10-30       Impact factor: 5.157

7.  Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

Authors:  Constanze Pagenstecher; Maria Wehner; Waltraut Friedl; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Marlies Sengteller; Wolfram Henn; Reinhard Buettner; Peter Propping; Elisabeth Mangold
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

Review 8.  DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets.

Authors:  Long Shan Li; Julio C Morales; Martina Veigl; David Sedwick; Sheldon Greer; Mark Meyers; Mark Wagner; Richard Fishel; David A Boothman
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

9.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

10.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.